| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 03/09/2005 | CN1589803A Application of 20(S)-panaxcoside -Rg3 in preparation of medicine for treating or preventing high blood pressure |
| 03/09/2005 | CN1589795A Nimodiping Freeze dried composition and its preparation method |
| 03/09/2005 | CN1589786A Composite effervescent preparation containing soya isoflavone |
| 03/09/2005 | CN1589785A Isosorbide dinitrate freeze dried powder ampoule and its preparation method |
| 03/09/2005 | CN1589784A 5-hydroxymethyl -2-furol and its derivative analogue medical use |
| 03/09/2005 | CN1192032C 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 03/09/2005 | CN1192019C Cyclic amine derivatives |
| 03/09/2005 | CN1192011C Calcium receptor-active arylalkyl amines |
| 03/09/2005 | CN1191860C Method for treatment of fibrosis using antagonist of integrin alpha-4 subunit |
| 03/09/2005 | CN1191856C Use of compounds that reduce alpha2-antiplasmin in vivo for the preparation of a composition for the treatment of ischemic stroke |
| 03/09/2005 | CN1191847C Medicated pillow its making process |
| 03/09/2005 | CN1191841C Chinese medicine liquid for treating sino-atrial bundle syndrome caused by deficiency of vital function and essence of heart and kidney |
| 03/09/2005 | CN1191837C Method for producing Chinese medicine for curing cardio-cerebrol vascular disease |
| 03/09/2005 | CN1191831C Compound Atenolol-Nifedipine slow releasing prepn |
| 03/09/2005 | CN1191830C Orally disintegrating Nifedipine prepn and its recipe |
| 03/08/2005 | US6864383 Ophthalmic compositions for treating ocular hypertension |
| 03/08/2005 | US6864380 Antiinflammatory agents; asthma; antiallergens; autoimmune diseases; antiarthritic agents |
| 03/08/2005 | US6864379 Stepwise alkylation of 5-substituted 1-(4-fluorophenyl)-1,3-dihydroisobenzofurans |
| 03/08/2005 | US6864368 Muscle relaxants, controlling immunology, sexual disorders, rheumatic diseases |
| 03/08/2005 | US6864355 Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| 03/08/2005 | US6864291 Agonists specific for the peripheral cannabinoid receptor |
| 03/08/2005 | US6864288 Regulation of phospholipase D activity |
| 03/08/2005 | US6864287 Cardiovascular disorders; hypotensive agents |
| 03/08/2005 | US6864282 9,11-cycloendoperoxide pro-drugs of prostaglandin analogues for treatment of ocular hypertension and glaucoma |
| 03/08/2005 | US6864280 Hypotensive agents; cardiovascular disorders |
| 03/08/2005 | US6864277 Brain diosrders; cardiovascular disorders; central nervous system disorders; psychological disorders |
| 03/08/2005 | US6864273 Dyspepsia; gastrointestinal disorders; irritable bowel disorders |
| 03/08/2005 | US6864263 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 03/08/2005 | US6864258 PH sensitivity; controlling blood concentration; cardiovascular disorders |
| 03/08/2005 | US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders |
| 03/08/2005 | US6864252 Treatment of cyclooxygenase mediated diseases, such as arthritis, neurodegeneration and colon cancer |
| 03/08/2005 | US6864249 Pharmaceutical compositions containing them are of the class of thrombin inhibitors which are useful as anticoagulants. |
| 03/08/2005 | US6864246 Anticholesterol agents |
| 03/08/2005 | US6864227 Artery-and vein-specific proteins and uses therefor |
| 03/08/2005 | US6864082 Modified viral surface proteins for binding to extracellular matrix components |
| 03/08/2005 | US6863902 Mixture of methyl hydrogen 9,11 alpha-epoxy-17 alpha-hydroxy-3-oxopregn-4-ene-7-alpha, 21-dicarboxylate, gamma-lactone and carriers administered as aldosterone receptor antagonists, for prophylaxis of cardiovascular disorders |
| 03/08/2005 | US6863901 Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration |
| 03/08/2005 | US6863647 2-Ureido-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 03/08/2005 | CA2480712A1 Chondrocyte therapeutic delivery system |
| 03/03/2005 | WO2005019245A1 Heptadepsin |
| 03/03/2005 | WO2005018673A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby |
| 03/03/2005 | WO2005018672A1 Drug containing chymase inhibitor as the active ingredient |
| 03/03/2005 | WO2005018649A1 Agent for inhibiting the formation of final saccharification product |
| 03/03/2005 | WO2005018642A1 Chemokine inhibiting piperazine derivatives and their use to treat myocarditis |
| 03/03/2005 | WO2005018635A2 Ion channel modulating activity i |
| 03/03/2005 | WO2005018626A1 Pharmaceutical composition comprising a combination of metformin and a statin |
| 03/03/2005 | WO2005018564A2 Compositions of a cyclooxygenase-2 selective inhibitor and a low-molecular-weight heparin for the treatment of central nervous system damage |
| 03/03/2005 | WO2005018531A2 Pharmaceutical compositions, azo-heterocyclic compounds and method for the production and use thereof |
| 03/03/2005 | WO2005018316A1 Hypertrophic cardiomyopathy model animal |
| 03/03/2005 | WO2004105766A3 Use of lornoxicam or lornoxicam analogue compounds |
| 03/03/2005 | WO2004104001A3 Pyrrolopyridine-2-carboxylic acid amide inhibitors of glycogen phoshorylase |
| 03/03/2005 | WO2004091476A3 Method of screening remedy for heart disease and medicinal composition for treating heart disease |
| 03/03/2005 | WO2004071395A3 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor ox1r (ox1r) |
| 03/03/2005 | WO2004063166A8 Heterocyclic ppar modulators |
| 03/03/2005 | WO2004001058A3 Transcription factor modulating compounds and methods of use thereof |
| 03/03/2005 | WO2003099315A8 A pharmaceutical composition comprising a retro-iverso isomer peptide |
| 03/03/2005 | WO2003089418A8 Indane acetic acid derivatives and their use as pharmaceutical agents |
| 03/03/2005 | WO2003050102A8 Novel compounds for the treatment of cardiac arrhythmia, synthesis, and methods of use |
| 03/03/2005 | WO2003042362A3 PGC-1β, A NOVEL PGC-1 HOMOLOGUE AND USES THEREFOR |
| 03/03/2005 | WO2003031405A3 Methods for the synthesis of substituted purines |
| 03/03/2005 | US20050050589 Soya cell strains with high isoflavone content |
| 03/03/2005 | US20050049424 6-Hydroxy isoflavones derivatives and medicaments involving same |
| 03/03/2005 | US20050049312 N-(1-adamantyl)alkyl]alkano-amidines, guanidines or N'-nitroguanidines; non-competitive receptor antagonists for the NMDA receptor |
| 03/03/2005 | US20050049303 Adamantane derivatives |
| 03/03/2005 | US20050049294 Methods of using [3.2.0] heterocyclic compounds and analogs thereof |
| 03/03/2005 | US20050049293 Increasing effect of released acetylcholine on hepatic muscarinic receptors |
| 03/03/2005 | US20050049283 Compounds that inhibit factor xa activity |
| 03/03/2005 | US20050049263 Purine analogs having hsp90-inhibiting activity |
| 03/03/2005 | US20050049261 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido{1,2-a}pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo{1,2-a}pyrimidin-5(1h)one derivatives |
| 03/03/2005 | US20050049259 Viricides; for the prophylaxis and treatment of herpes viral infections |
| 03/03/2005 | US20050049254 Substituted heterocyclic compounds |
| 03/03/2005 | US20050049251 Inhibitors of p38 |
| 03/03/2005 | US20050049250 7-Aikyl and cycloalkyl-substituted imidazotriazinones |
| 03/03/2005 | US20050049246 Such as [3-(2-Bromo-ethoxy)-phenyl]-[4-(3-cyclohexyl-5-methyl-isoxazol-4-yl)-pyrimidin-2-yl]-amine |
| 03/03/2005 | US20050049233 Transdermal administering of testosterone |
| 03/03/2005 | US20050049212 Eating disorders, cachexia, diabetes mellitus, hypertension, coronary heart disease, hypercholesterolemia, osteoarthritis, gallstones, cancers of the reproductive organs, and sleep apnea; drug screening; diagnosis and therapy; kits; regulates metabolism of triglycerides |
| 03/03/2005 | US20050049205 Product from rose hips e.g. 3- beta -D-galactopyranosyloxy-2-(octadeca-9Z,12Z,15Z-trienoyloxy)propanyl octadeca-9Z,12Z,15Z-trienoate (GOPO); arthritis and osteoarthritis |
| 03/03/2005 | US20050049202 For treating disorders associated with excessive cytokine release such as interleukin-1 (IL-1) for example infection, cancer, asthma, coronary restenosis, autoimmune disease, cirrhosis, entotoxemia, reperfusion injury and septic shock; lactone or lactam-benzoates or benzamides |
| 03/03/2005 | US20050049198 Contacting a cardiac ryanodine receptor (RyR2) with a fragment of a dihydropyridine receptor (DHPR) polypeptide; ischemic heart disease, congestive heart failure, cardiac hypertrophy (calcium overload), dysrhythmia, or heart attack, cardiomyopathy |
| 03/03/2005 | US20050049190 Cation conducting gabaa receptors and their use |
| 03/03/2005 | US20050049174 Reducing the severity of hemodynamic instability in a subject undergoing cardiac surgery involving an extra-corporal circulation by administration through inhalation of a therapeutically effective amount of a vasodilatator to the subject |
| 03/03/2005 | US20050048639 Caspase-8 binding protein, its preparation and use |
| 03/03/2005 | US20050048488 Expression vector comprising nucleotide sequences coding excitatory amino acid transporter 2 (EAAT2) proteins for use in identifying modulator for treatment and preention of neurological or psychiatric disorder |
| 03/03/2005 | US20050048479 Adenylyl and guanylyl cyclases |
| 03/03/2005 | US20050048137 Extract of plant dendrobii caulis and preparing process thereof |
| 03/03/2005 | US20050048135 Mixture containing plant extract; renin, angiogenesis inhibitor; cardiovascular disorders; antidiabetic agents; liver disorders; gall stones; gastrointestinal disorders |
| 03/03/2005 | US20050048104 Transdermal drug delivery devices comprising a polyurethane drug reservoir |
| 03/03/2005 | US20050048055 Use of CD40 engagement to alter T cell receptor usage |
| 03/03/2005 | US20050048052 Bioassay for detecting expression of mammalian CC-chemokine receptor 2, by binding of antibody or antigen-binding fragment; human or humanized monoclonal antibody; test kits |
| 03/03/2005 | US20050048039 Administering exogenous monocyte cells loaded with corrective agent; chemotactic factor for macrophages; diagnosis of bone disorders, anticarcinogenic agents, rheumatic disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; multiple sclerosis; stroke |
| 03/03/2005 | US20050048035 Methods of using regenerative cells in the treatment of stroke and related diseases and disorders |
| 03/03/2005 | US20050048034 Using adipose stem cells to treat ischemic ulcer, diabetic and traumatic wounds; regenerative medicine |
| 03/03/2005 | US20050048028 Use of the insulin-like-growth factor i splice variant mgf for the prevention of myocardial damage |
| 03/03/2005 | US20050048027 Non-neurotoxic plasminogen activating factors for treating stroke |
| 03/03/2005 | US20050048026 Remedies for ischemic diseases |
| 03/03/2005 | US20050047958 Methods for sterilizing preparations of digestive enzymes |
| 03/03/2005 | CA2536435A1 Drug containing chymase inhibitor as the active ingredient |
| 03/03/2005 | CA2536089A1 Ppar modulators |
| 03/03/2005 | CA2535585A1 Pharmaceutical composition for preventing or remedying cardiac hypertrophy and cardiocascular disease caused thereby |
| 03/03/2005 | CA2535516A1 Silencing of tgf-beta receptor type ii expression by sirna |